BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moss AC, Anton P, Savidge T, Newman P, Cheifetz AS, Gay J, Paraschos S, Winter MW, Moyer MP, Karalis K, Kokkotou E, Pothoulakis C. Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha. Gut 2007;56:1210-7. [PMID: 17412781 DOI: 10.1136/gut.2006.110668] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Buckinx R, Bagyanszki M, Avula LR, Adriaensen D, Van Nassauw L, Timmermans J. Expression of corticotropin-releasing factor and urocortins in the normal and Schistosoma mansoni-infected mouse ileum. Cell Tissue Res 2015;359:453-63. [DOI: 10.1007/s00441-014-2012-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Koon HW, Zhao D, Xu H, Bowe C, Moss A, Moyer MP, Pothoulakis C. Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis. Am J Pathol 2008;173:400-10. [PMID: 18599605 DOI: 10.2353/ajpath.2008.080222] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
3 Jia D, Dou Y, Li Z, Zhou X, Gao Y, Chen K, Cong W, Ma M, Wu Z, Li W. Design, synthesis and evaluation of a baicalin and berberine hybrid compound as therapeutic agent for ulcerative colitis. Bioorg Med Chem 2020;28:115697. [PMID: 33069077 DOI: 10.1016/j.bmc.2020.115697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Zhang M, Sun K, Wu Y, Yang Y, Tso P, Wu Z. Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease. Front Immunol 2017;8:942. [PMID: 28855901 DOI: 10.3389/fimmu.2017.00942] [Cited by in Crossref: 105] [Cited by in F6Publishing: 95] [Article Influence: 21.0] [Reference Citation Analysis]
5 Novembri R, De Clemente C, Funghi L, Torricelli M, Voltolini C, Challis JR, Petraglia F. Corticotropin releasing hormone and Urocortin 2 activate inflammatory pathways in cultured trophoblast cell lines. Eur J Obstet Gynecol Reprod Biol 2015;195:200-5. [PMID: 26588439 DOI: 10.1016/j.ejogrb.2015.10.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Hoffman JM, Baritaki S, Ruiz JJ, Sideri A, Pothoulakis C. Corticotropin-Releasing Hormone Receptor 2 Signaling Promotes Mucosal Repair Responses after Colitis. Am J Pathol. 2016;186:134-144. [PMID: 26597886 DOI: 10.1016/j.ajpath.2015.09.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
7 Pelissier-Rota M, Chartier NT, Bonaz B, Jacquier-Sarlin MR. A crosstalk between muscarinic and CRF2 receptors regulates cellular adhesion properties of human colon cancer cells. Biochim Biophys Acta Mol Cell Res 2017;1864:1246-59. [PMID: 28432022 DOI: 10.1016/j.bbamcr.2017.04.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Novembri R, Carrarelli P, Toti P, Rocha AL, Borges LE, Reis FM, Piomboni P, Florio P, Petraglia F. Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response. Mol Hum Reprod. 2011;17:587-593. [PMID: 21454316 DOI: 10.1093/molehr/gar020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang R, Li S. COX-2 as a novel target of CRF family peptides’ participating in inflammation. Biochemical and Biophysical Research Communications 2009;382:483-5. [DOI: 10.1016/j.bbrc.2009.03.064] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
10 Baritaki S, de Bree E, Chatzaki E, Pothoulakis C. Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular Crosstalk. J Clin Med 2019;8:E1669. [PMID: 31614860 DOI: 10.3390/jcm8101669] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
11 Yuan PQ, Wu SV, Pothoulakis C, Taché Y. Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect. Am J Physiol Gastrointest Liver Physiol 2016;310:G387-98. [PMID: 26744472 DOI: 10.1152/ajpgi.00337.2015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
12 Yang L, Zheng PY, Liu ZQ. Activation of TLR4 by CRF in human intestinal epithelial cells is mediated by the CRF2 receptor. Shijie Huaren Xiaohua Zazhi 2012; 20(19): 1763-1767 [DOI: 10.11569/wcjd.v20.i19.1763] [Reference Citation Analysis]
13 Paschos KA, Kolios G, Chatzaki E. The corticotropin-releasing factor system in inflammatory bowel disease: prospects for new therapeutic approaches. Drug Discov Today. 2009;14:713-720. [PMID: 19379831 DOI: 10.1016/j.drudis.2009.04.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
14 Taché Y, Million M. Role of Corticotropin-releasing Factor Signaling in Stress-related Alterations of Colonic Motility and Hyperalgesia. J Neurogastroenterol Motil 2015;21:8-24. [PMID: 25611064 DOI: 10.5056/jnm14162] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 8.4] [Reference Citation Analysis]
15 Kiank C, Taché Y, Larauche M. Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors. Brain Behav Immun. 2010;24:41-48. [PMID: 19698778 DOI: 10.1016/j.bbi.2009.08.006] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
16 Chang J, Adams MR, Clifton MS, Liao M, Brooks JH, Hasdemir B, Bhargava A. Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2. Am J Physiol Gastrointest Liver Physiol. 2011;300:G884-G894. [PMID: 21330446 DOI: 10.1152/ajpgi.00319.2010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
17 Rodiño-Janeiro BK, Alonso-Cotoner C, Pigrau M, Lobo B, Vicario M, Santos J. Role of Corticotropin-releasing Factor in Gastrointestinal Permeability. J Neurogastroenterol Motil 2015;21:33-50. [PMID: 25537677 DOI: 10.5056/jnm14084] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
18 Pothoulakis C, Torre-Rojas M, Duran-Padilla MA, Gevorkian J, Zoras O, Chrysos E, Chalkiadakis G, Baritaki S. CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis. Int J Cancer 2018;142:334-46. [PMID: 28929494 DOI: 10.1002/ijc.31064] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
19 Mahurkar-Joshi S, Chang L. Epigenetic Mechanisms in Irritable Bowel Syndrome. Front Psychiatry 2020;11:805. [PMID: 32922317 DOI: 10.3389/fpsyt.2020.00805] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zhu C, Sun Z, Li C, Guo R, Li L, Jin L, Wan R, Li S. Urocortin affects migration of hepatic cancer cell lines via differential regulation of cPLA2 and iPLA2. Cell Signal 2014;26:1125-34. [PMID: 24518041 DOI: 10.1016/j.cellsig.2014.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
21 Chandras C, Koutmani Y, Kokkotou E, Pothoulakis C, Karalis KP. Activation of phosphatidylinositol 3-kinase/protein kinase B by corticotropin-releasing factor in human monocytes. Endocrinology 2009;150:4606-14. [PMID: 19628576 DOI: 10.1210/en.2008-1810] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
22 Nozu T, Kumei S, Takakusaki K, Okumura T. Water-avoidance stress enhances gastric contractions in freely moving conscious rats: role of peripheral CRF receptors. J Gastroenterol 2014;49:799-805. [PMID: 23645119 DOI: 10.1007/s00535-013-0828-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
23 Emeto T, Moxon J, Biros E, Rush C, Clancy P, Woodward L, Moran C, Jose R, Nguyen T, Walker P, Golledge J. Urocortin 2 is associated with abdominal aortic aneurysm and mediates anti-proliferative effects on vascular smooth muscle cells via corticotrophin releasing factor receptor 2. Clinical Science 2014;126:517-27. [DOI: 10.1042/cs20130425] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
24 Manning J, Buckley MM, O'Halloran KD, O'Malley D. Combined XIL-6R and urocortin-2 treatment restores MDX diaphragm muscle force. Muscle Nerve 2017;56:E134-40. [PMID: 28294390 DOI: 10.1002/mus.25644] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
25 Rodriguez JA, Huerta-Yepez S, Law IK, Baay-Guzman GJ, Tirado-Rodriguez B, Hoffman JM, Iliopoulos D, Hommes DW, Verspaget HW, Chang L, Pothoulakis C, Baritaki S. Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signaling. Cell Mol Gastroenterol Hepatol 2015;1:610-30. [PMID: 26495412 DOI: 10.1016/j.jcmgh.2015.08.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
26 Voltolini C, Battersby S, Novembri R, Torricelli M, Severi FM, Petraglia F, Norman JE. Urocortin 2 role in placental and myometrial inflammatory mechanisms at parturition. Endocrinology. 2015;156:670-679. [PMID: 25426872 DOI: 10.1210/en.2014-1432] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
27 Buckinx R, Adriaensen D, Nassauw LV, Timmermans JP. Corticotrophin-releasing factor, related peptides, and receptors in the normal and inflamed gastrointestinal tract. Front Neurosci. 2011;5:54. [PMID: 21541251 DOI: 10.3389/fnins.2011.00054] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
28 Yamawaki H, Futagami S, Sakasegawa N, Murakami M, Agawa S, Ikeda G, Noda H, Kirita K, Gudis K, Higuchi K, Kodaka Y, Ueki N, Iwakiri K. Acotiamide attenuates central urocortin 2-induced intestinal inflammatory responses, and urocortin 2 treatment reduces TNF-α productions in LPS-stimulated macrophage cell lines. Neurogastroenterol Motil 2020;32:e13813. [PMID: 32030855 DOI: 10.1111/nmo.13813] [Reference Citation Analysis]
29 Kavanaugh DW, O'Callaghan J, Buttó LF, Slattery H, Lane J, Clyne M, Kane M, Joshi L, Hickey RM. Exposure of Bifidobacterium longum subsp. infantis to Milk Oligosaccharides Increases Adhesion to Epithelial Cells and Induces a Substantial Transcriptional Response. PLoS One 2013;8:e67224. [PMID: 23805302 DOI: 10.1371/journal.pone.0067224] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 7.0] [Reference Citation Analysis]
30 Chatzaki E, Anton PA, Million M, Lambropoulou M, Constantinidis T, Kolios G, Taché Y, Grigoriadis DE. Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: Down-regulation in ulcerative colitis. World J Gastroenterol 2013; 19(9): 1416-1423 [PMID: 23539366 DOI: 10.3748/wjg.v19.i9.1416] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
31 Chang L, Adeyemo M, Karagiannides I, Videlock EJ, Bowe C, Shih W, Presson AP, Yuan PQ, Cortina G, Gong H. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol. 2012;107:262-272. [PMID: 22158028 DOI: 10.1038/ajg.2011.423] [Cited by in Crossref: 98] [Cited by in F6Publishing: 93] [Article Influence: 8.9] [Reference Citation Analysis]
32 Chen H, Shi H, Liu Y, Ren X, He S, Chang X, Yin Y. Activation of corticotropin-releasing factor receptor 1 aggravates dextran sodium sulphate-induced colitis in mice by promoting M1 macrophage polarization. Mol Med Rep 2018;17:234-42. [PMID: 29115460 DOI: 10.3892/mmr.2017.7909] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
33 Zhang R, Xu Y, Fu H, Wang J, Jin L, Li S. Urocortin induced expression of COX-2 and ICAM-1 via corticotrophin-releasing factor type 2 receptor in rat aortic endothelial cells. Br J Pharmacol 2009;158:819-29. [PMID: 19694731 DOI: 10.1111/j.1476-5381.2009.00346.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
34 Alonso C, Vicario M, Pigrau M, Lobo B, Santos J. Intestinal barrier function and the brain-gut axis. Adv Exp Med Biol. 2014;817:73-113. [PMID: 24997030 DOI: 10.1007/978-1-4939-0897-4_4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
35 Ducarouge B, Pelissier-Rota M, Powell R, Buisson A, Bonaz B, Jacquier-Sarlin M. Involvement of CRF2 signaling in enterocyte differentiation. World J Gastroenterol 2017; 23(28): 5127-5145 [PMID: 28811708 DOI: 10.3748/wjg.v23.i28.5127] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
36 Santos J, Yates D, Guilarte M, Vicario M, Alonso C, Perdue MH. Stress neuropeptides evoke epithelial responses via mast cell activation in the rat colon. Psychoneuroendocrinology. 2008;33:1248-1256. [PMID: 18691825 DOI: 10.1016/j.psyneuen.2008.07.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
37 Im E. Multi-facets of Corticotropin-releasing Factor in Modulating Inflammation and Angiogenesis. J Neurogastroenterol Motil 2015;21:25-32. [PMID: 25540945 DOI: 10.5056/jnm14076] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
38 Li Y, Song Z, Kerr KA, Moeser AJ. Chronic social stress in pigs impairs intestinal barrier and nutrient transporter function, and alters neuro-immune mediator and receptor expression. PLoS One 2017;12:e0171617. [PMID: 28170426 DOI: 10.1371/journal.pone.0171617] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
39 Liu ZH, Shen TY, Zhang P, Ma YL, Moyer MP, Qin HL. Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460. World J Gastroenterol 2010; 16(45): 5759-5765 [PMID: 21128328 DOI: 10.3748/wjg.v16.i45.5759] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
40 van Ingen G, Li J, Goedegebure A, Pandey R, Li YR, March ME, Jaddoe VW, Bakay M, Mentch FD, Thomas K, Wei Z, Chang X, Hain HS, Uitterlinden AG, Moll HA, van Duijn CM, Rivadeneira F, Raat H, Baatenburg de Jong RJ, Sleiman PM, van der Schroeff MP, Hakonarson H. Genome-wide association study for acute otitis media in children identifies FNDC1 as disease contributing gene. Nat Commun 2016;7:12792. [PMID: 27677580 DOI: 10.1038/ncomms12792] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
41 Pintér E, Pozsgai G, Hajna Z, Helyes Z, Szolcsányi J. Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions. Br J Clin Pharmacol 2014;77:5-20. [PMID: 23432438 DOI: 10.1111/bcp.12097] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
42 Novembri R, Torricelli M, Bloise E, Conti N, Galeazzi L, Severi F, Petraglia F. Effects of urocortin 2 and urocortin 3 on IL-10 and TNF-α expression and secretion from human trophoblast explants. Placenta 2011;32:969-74. [DOI: 10.1016/j.placenta.2011.09.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
43 Li JJ, Ren WJ, Yin HY, Zhao YF, Tang Y. Underlying mechanisms for intestinal diseases arising from stress. Shijie Huaren Xiaohua Zazhi 2020; 28(14): 617-627 [DOI: 10.11569/wcjd.v28.i14.617] [Reference Citation Analysis]
44 Lyte M, Vulchanova L, Brown DR. Stress at the intestinal surface: catecholamines and mucosa-bacteria interactions. Cell Tissue Res. 2011;343:23-32. [PMID: 20941511 DOI: 10.1007/s00441-010-1050-0] [Cited by in Crossref: 150] [Cited by in F6Publishing: 133] [Article Influence: 12.5] [Reference Citation Analysis]
45 Nozu T, Takakusaki K, Okumura T. Urocortin 2 blocks the suppression of gastric antral contractions induced by lipopolysaccharide in freely moving conscious rats. Regul Pept 2014;190-191:12-7. [PMID: 24793550 DOI: 10.1016/j.regpep.2014.04.004] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Liu S, Chang J, Long N, Beckwith K, Talhouarne G, Brooks JJ, Qu MH, Ren W, Wood JD, Cooper S, Bhargava A. Endogenous CRF in rat large intestine mediates motor and secretory responses to stress. Neurogastroenterol Motil 2016;28:281-91. [PMID: 26611915 DOI: 10.1111/nmo.12725] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
47 Kokkotou E, Moss AC, Torres D, Karagiannides I, Cheifetz A, Liu S, O’Brien M, Maratos-Flier E, Pothoulakis C. Melanin-concentrating hormone as a mediator of intestinal inflammation. Proc Natl Acad Sci USA. 2008;105:10613-10618. [PMID: 18650383 DOI: 10.1073/pnas.0804536105] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
48 Gay J, Kokkotou E, O'Brien M, Pothoulakis C, Karalis KP. Corticotropin-releasing hormone deficiency is associated with reduced local inflammation in a mouse model of experimental colitis. Endocrinology. 2008;149:3403-3409. [PMID: 18403481 DOI: 10.1210/en.2007-1703] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
49 Zhu H, Wang J, Li J, Li S. Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery? Inflamm Res 2011;60:715-21. [DOI: 10.1007/s00011-011-0329-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
50 Campos-Salinas J, Caro M, Cavazzuti A, Forte-Lago I, Beverley SM, O'Valle F, Gonzalez-Rey E. Protective role of the neuropeptide urocortin II against experimental sepsis and leishmaniasis by direct killing of pathogens. J Immunol 2013;191:6040-51. [PMID: 24249730 DOI: 10.4049/jimmunol.1301921] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
51 Hao Z, Huang Y, Cleman J, Jovin IS, Vale WW, Bale TL, Giordano FJ. Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation. Proc Natl Acad Sci U S A 2008;105:3939-44. [PMID: 18308934 DOI: 10.1073/pnas.0712366105] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
52 Qiu Y, Jiang Z, Hu S, Wang L, Ma X, Yang X. Lactobacillus plantarum Enhanced IL-22 Production in Natural Killer (NK) Cells That Protect the Integrity of Intestinal Epithelial Cell Barrier Damaged by Enterotoxigenic Escherichia coli. Int J Mol Sci 2017;18:E2409. [PMID: 29137183 DOI: 10.3390/ijms18112409] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
53 Gu X, Qi P, Zhou F, Ji Q, Wang H, Dou T, Zhao Y, Gao C. An intronic polymorphism in the corticotropin-releasing hormone receptor 2 gene increases susceptibility to HBV-related hepatocellular carcinoma in Chinese population. Hum Genet 2010;127:75-81. [PMID: 19813023 DOI: 10.1007/s00439-009-0750-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
54 Inada Y, Ikeda K, Tojo K, Sakamoto M, Takada Y, Tajima N. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation. Peptides 2009;30:365-72. [PMID: 19026699 DOI: 10.1016/j.peptides.2008.10.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]